{"id":61453,"date":"2025-06-19T13:03:04","date_gmt":"2025-06-19T11:03:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/"},"modified":"2025-06-19T13:03:04","modified_gmt":"2025-06-19T11:03:04","slug":"phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/","title":{"rendered":"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications<\/i><\/p>\n<p>SEATTLE&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fphasegenomics.com%2F&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=Phase+Genomics%2C+Inc.&amp;index=1&amp;md5=8857003150af2252066443a0a1838af2\" rel=\"nofollow\" shape=\"rect\">Phase Genomics, Inc.<\/a>, a leader in genomic technology development, today announced the launch of its new <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=ProxiMeta+Starter+and+Elite+Bundles&amp;index=2&amp;md5=eb056246e0fc6bf65a196ed43a568219\" rel=\"nofollow\" shape=\"rect\">ProxiMeta Starter and Elite Bundles<\/a>, comprehensive product offerings that make genome- and mobilome-resolved metagenomics more accessible for researchers across microbiome, environmental and public health applications. Built on Phase Genomics\u2019 award-winning Hi-C metagenomics platform, the streamlined, full-service solutions accelerate discovery from within complex microbial communities.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/5\/PG_Horiz_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/5\/PG_Horiz_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/21\/PG_Horiz_Logo.jpg\"><\/a><\/p>\n<p>\n\u201cWe built the ProxiMeta bundles to meet researchers exactly where they are, whether just getting started or leading large-scale research projects. Research doesn\u2019t look the same today as it did even last year. Labs are being asked to do more with fewer resources across the board, and we\u2019re here to help,\u201d said Ivan Liachko, PhD, CEO and co-founder of Phase Genomics. \u201cThe ProxiMeta bundles offer a flexible platform that evolves with a researcher\u2019s career and their science.\u201d<\/p>\n<p>\nThe two new bundles provide a scalable entry point for new users and a hands-off option for labs looking to outsource highly specialized technical workflows. The Starter and Elite bundles for Hi-C metagenomics combine robust sequencing, dynamic bioinformatics and personalized scientific support into ready-to-use formats, without the constraints of 16S-based techniques or culturing.<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<span class=\"bwuline\">The ProxiMeta Starter Bundle<\/span> is tailored for early-career researchers new to next-generation metagenomics, offering an affordable on-ramp to advanced microbial insights for up to two samples with guaranteed success on library prep. If the initial library preparation fails, Phase Genomics will re-prep the sample at no additional cost. Starter includes hands-on support from Phase Genomics scientists. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=Learn+more+here&amp;index=3&amp;md5=d1846297e68e7b9e61152d57ce05b78f\" rel=\"nofollow\" shape=\"rect\">Learn more here<\/a><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=.&amp;index=4&amp;md5=82ee03cb34a5422c74fdfe1aec7485f3\" rel=\"nofollow\" shape=\"rect\">.<\/a><\/li>\n<li>\n<span class=\"bwuline\">The ProxiMeta Elite Bundle<\/span> offers a turnkey, remote extension of lab operations for experienced investigators with active funding and limited bench time. The bundle includes deep metagenomic shotgun sequencing and Hi-C assembly for up to eight samples, performed entirely in-house at Phase Genomics. <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=Learn+more+here&amp;index=5&amp;md5=72044cd058c3f303c68d3842c56f6ec5\" rel=\"nofollow\" shape=\"rect\">Learn more here<\/a><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=.&amp;index=6&amp;md5=8f4caad9619f7eb9906740af99ed725d\" rel=\"nofollow\" shape=\"rect\">.<\/a><\/li>\n<\/ul>\n<p>\nProxiMeta Classic is still available as an \u00e0 la carte option for researchers who prefer to customize their project scope or perform sequencing and analysis in-house. Classic delivers the same high-resolution capabilities with the flexibility of tailored support when needed.<\/p>\n<p>\nThe ProxiMeta platform has been <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fphasegenomics.com%2Fresources-and-support%2Fpublications-news%2Fmetagenomics-microbiology%2F&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=heavily+cited+in+leading+peer-reviewed+journals&amp;index=7&amp;md5=e46203ad14478e2d583397b29009112e\" rel=\"nofollow\" shape=\"rect\">heavily cited in leading peer-reviewed journals<\/a> for its ability to generate high-quality genomes, resolve microbial population structure and link mobile genetic elements like plasmids and phages to their microbial hosts. The ProxiMeta Starter and Elite Bundles are available beginning today, June 19, 2025. For more information or to request a consultation, stop by booth 1109 at ASM 2025 or visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=https%3A%2F%2Finfo.phasegenomics.com%2Fproximeta-bundles&amp;index=8&amp;md5=72586d47955828735f8597f3874c75cf\" rel=\"nofollow\" shape=\"rect\">https:\/\/info.phasegenomics.com\/proximeta-bundles<\/a>.<\/p>\n<p>\nFollow Phase Genomics on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fphasegenomics&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=X&amp;index=9&amp;md5=cd4c8be7ae50d24bdf9c2bd917200713\" rel=\"nofollow\" shape=\"rect\">X<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fphase-genomics-inc%2F&amp;esheet=54278881&amp;newsitemid=20250619015652&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=10&amp;md5=1bfff0289f2c5eddb796b3f5c16e7dea\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a> for the latest information.<\/p>\n<p>\n<b>About Phase Genomics<\/b><\/p>\n<p>\nPhase Genomics applies proprietary ultra-long-range genome sequencing technology to enable genome assembly, microbiome discovery, as well as analysis of genomic integrity and chromosomal aberrations. In addition to a comprehensive portfolio of laboratory and computational services and products, including reagent kits and genomic services, they also offer an industry-leading genome and metagenome assembly and analysis software. Based in Seattle, WA, the company was founded in 2015 by a team of genome scientists, software engineers, and entrepreneurs. The company\u2019s mission is to empower scientists with genomic tools that accelerate breakthrough discoveries.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>Eric Schudiske<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;l&#x74;&#111;&#x3a;&#101;r&#x69;c&#x40;&#115;&#x32;&#115;&#x70;&#114;&#46;&#x63;o&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#101;&#114;&#x69;c&#64;&#x73;&#x32;s&#112;&#x72;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications SEATTLE&#8211;(BUSINESS WIRE)&#8211;Phase Genomics, Inc., a leader in genomic technology development, today announced the launch of its new ProxiMeta Starter and Elite Bundles, comprehensive product offerings that make genome- and mobilome-resolved metagenomics &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61453","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications SEATTLE&#8211;(BUSINESS WIRE)&#8211;Phase Genomics, Inc., a leader in genomic technology development, today announced the launch of its new ProxiMeta Starter and Elite Bundles, comprehensive product offerings that make genome- and mobilome-resolved metagenomics ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-19T11:03:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics\",\"datePublished\":\"2025-06-19T11:03:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/\"},\"wordCount\":556,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250619015652\\\/en\\\/2502056\\\/22\\\/PG_Horiz_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/\",\"name\":\"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250619015652\\\/en\\\/2502056\\\/22\\\/PG_Horiz_Logo.jpg\",\"datePublished\":\"2025-06-19T11:03:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250619015652\\\/en\\\/2502056\\\/22\\\/PG_Horiz_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250619015652\\\/en\\\/2502056\\\/22\\\/PG_Horiz_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/","og_locale":"en_US","og_type":"article","og_title":"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics - Pharma Trend","og_description":"The new suite of products unlocks greater access to Hi-C metagenomic research, accelerating discovery from complex microbial communities in human and environmental research applications SEATTLE&#8211;(BUSINESS WIRE)&#8211;Phase Genomics, Inc., a leader in genomic technology development, today announced the launch of its new ProxiMeta Starter and Elite Bundles, comprehensive product offerings that make genome- and mobilome-resolved metagenomics ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/","og_site_name":"Pharma Trend","article_published_time":"2025-06-19T11:03:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics","datePublished":"2025-06-19T11:03:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/"},"wordCount":556,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/","url":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/","name":"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg","datePublished":"2025-06-19T11:03:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250619015652\/en\/2502056\/22\/PG_Horiz_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/phase-genomics-launches-proximeta-starter-and-elite-bundles-to-expand-access-to-genome-resolved-metagenomics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Phase Genomics Launches ProxiMeta\u2122 Starter and Elite Bundles to Expand Access to Genome-Resolved Metagenomics"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61453"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61453\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}